Arcturus Therapeutics Holdings Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ARCT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,100

Value ($000)

7

Weight

0.0%

2020 Q2 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	7	0.0%	1,100	12/31/2025
2025 Q1	5/19/2025	503	0.0%	47,452	3/31/2025
2024 Q4	2/14/2025	886	0.0%	52,189	12/31/2024
2024 Q3	11/14/2024	4,776	0.0%	205,756	9/30/2024
2024 Q2	8/14/2024	5,005	0.0%	205,552	6/30/2024
2024 Q1	5/15/2024	6,092	0.0%	180,398	3/31/2024
2023 Q4	2/14/2024	818	0.0%	25,954	12/31/2023
2023 Q3	11/13/2023	594	0.0%	23,247	9/30/2023
2023 Q2	8/11/2023	405	0.0%	16,895	6/30/2023
2023 Q1	5/15/2023	405	0.0%	16,895	3/31/2023
2022 Q1	5/16/2022	477	0.0%	17,692	3/31/2022
2021 Q4	2/14/2022	655	0.0%	17,692	12/31/2021
2021 Q3	11/15/2021	905	0.0%	18,945	9/30/2021
2021 Q2	8/16/2021	632	0.0%	18,676	6/30/2021
2021 Q1	5/14/2021	670	0.0%	16,225	3/31/2021
2020 Q4	3/1/2021	633	0.0%	14,600	12/31/2020
2020 Q3	11/13/2020	613	0.0%	14,300	9/30/2020
2020 Q2	8/14/2020	519	0.0%	11,100	6/30/2020